CUE BIOPHARMA INC (CUE:NASDAQ)
$27.54 -0.95 (-3.3345%)
Analysed CUE BIOPHARMA INC (CUE:NASDAQ) News Sources
Cue Biopharma Names Shao-Lee Lin M.D., Ph.D., CEO, President and Board Director to Lead Continued Growth and Transformation into a Clinical-Stage Company
30-04-2026
yahoo.com
Cue Biopharma Expands Pipeline with Exclusive License from Ascendant Health Sciences Ltd. for Clinical-Stage Dual-Mechanism Anti-IgE Antibody
30-04-2026
yahoo.com
Cue Biopharma Announces $30 Million Private Placement
30-04-2026
yahoo.com
Cue Biopharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07-05-2026
yahoo.com
Cue Biopharma Reports First Quarter 2026 Financial Results and Recent Strategic Developments
14-05-2026
yahoo.com
Cue Biopharma to Present at the 2026 Jefferies Global Healthcare Conference
21-05-2026
yahoo.com
Cue Biopharma Announces Board Transition and Addition of New Directors with Continued Company Evolution
02-06-2026
yahoo.com
Cue Biopharma Announces $50.0 Million Private Placement
10-07-2026
yahoo.com
Cue Biopharma Appoints Dominic Borie, M.D., Ph.D., as Chief Medical Officer and Head of Research & Development
13-07-2026
yahoo.com
Head and Neck Squamous Cell Carcinoma Market is Projected to Boost at a CAGR of 10.5% During the Forecast Period (2026–2036) Due to the Launch of Emerging Novel Immunotherapies | DelveInsight
13-07-2026
yahoo.com
What is the current price of CUE BIOPHARMA INC (CUE:NASDAQ)?
The current price of CUE BIOPHARMA INC (CUE:NASDAQ) is $27.54.
CUE BIOPHARMA INC (CUE:NASDAQ) absolute price change since previous trading day?
The absolute price change of CUE BIOPHARMA INC (CUE:NASDAQ) since the previous trading day is $-0.95.
CUE BIOPHARMA INC (CUE:NASDAQ) percentage price change since previous trading day?
The percentage price change of CUE BIOPHARMA INC (CUE:NASDAQ) since the previous trading day is -3.3345%.
What is the most recent average sentiment score for CUE BIOPHARMA INC (CUE:NASDAQ)?
The most recent average sentiment score for CUE BIOPHARMA INC (CUE:NASDAQ) is 83 out of 100.
What is the most recent average sentiment for CUE BIOPHARMA INC (CUE:NASDAQ)?
The most recent sentiment for CUE BIOPHARMA INC (CUE:NASDAQ) is .
SEC-8K** Filing Available For CUE BIOPHARMA INC (CUE:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.